UniProt ID | UBAP1_HUMAN | |
---|---|---|
UniProt AC | Q9NZ09 | |
Protein Name | Ubiquitin-associated protein 1 | |
Gene Name | UBAP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 502 | |
Subcellular Localization | Cytoplasm, cytosol . Endosome . Predominantly cytosolic. Recruited to endosomes as part of the ESCRT-I complex. | |
Protein Description | Component of the ESCRT-I complex, a regulator of vesicular trafficking process. Binds to ubiquitinated cargo proteins and is required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies (MVBs). Plays a role in the proteasomal degradation of ubiquitinated cell-surface proteins, such as EGFR and BST2.. | |
Protein Sequence | MASKKLGADFHGTFSYLDDVPFKTGDKFKTPAKVGLPIGFSLPDCLQVVREVQYDFSLEKKTIEWAEEIKKIEEAEREAECKIAEAEAKVNSKSGPEGDSKMSFSKTHSTATMPPPINPILASLQHNSILTPTRVSSSATKQKVLSPPHIKADFNLADFECEEDPFDNLELKTIDEKEELRNILVGTTGPIMAQLLDNNLPRGGSGSVLQDEEVLASLERATLDFKPLHKPNGFITLPQLGNCEKMSLSSKVSLPPIPAVSNIKSLSFPKLDSDDSNQKTAKLASTFHSTSCLRNGTFQNSLKPSTQSSASELNGHHTLGLSALNLDSGTEMPALTSSQMPSLSVLSVCTEESSPPNTGPTVTPPNFSVSQVPNMPSCPQAYSELQMLSPSERQCVETVVNMGYSYECVLRAMKKKGENIEQILDYLFAHGQLCEKGFDPLLVEEALEMHQCSEEKMMEFLQLMSKFKEMGFELKDIKEVLLLHNNDQDNALEDLMARAGAS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Acetylation | ----MASKKLGADFH ----CCCCCCCCCCC | 42.34 | 19821673 | |
41 | Phosphorylation | VGLPIGFSLPDCLQV CCCCCCCCHHHHHHH | 33.50 | 28348404 | |
49 (in isoform 4) | Phosphorylation | - | 2.52 | 24247654 | |
49 (in isoform 3) | Phosphorylation | - | 2.52 | 24247654 | |
61 | Ubiquitination | YDFSLEKKTIEWAEE CCCCCCHHHHHHHHH | 45.41 | - | |
89 (in isoform 2) | Ubiquitination | - | 33.19 | 21890473 | |
89 | Ubiquitination | KIAEAEAKVNSKSGP HHHHHHHHHCCCCCC | 33.19 | 21906983 | |
92 | Phosphorylation | EAEAKVNSKSGPEGD HHHHHHCCCCCCCCC | 31.05 | - | |
93 (in isoform 2) | Ubiquitination | - | 54.98 | 21890473 | |
93 | Ubiquitination | AEAKVNSKSGPEGDS HHHHHCCCCCCCCCC | 54.98 | 21906983 | |
94 | Phosphorylation | EAKVNSKSGPEGDSK HHHHCCCCCCCCCCC | 60.44 | - | |
100 | Phosphorylation | KSGPEGDSKMSFSKT CCCCCCCCCCCCCCC | 40.91 | - | |
101 | Ubiquitination | SGPEGDSKMSFSKTH CCCCCCCCCCCCCCC | 43.22 | - | |
103 | Phosphorylation | PEGDSKMSFSKTHST CCCCCCCCCCCCCCC | 30.06 | 24719451 | |
105 | Phosphorylation | GDSKMSFSKTHSTAT CCCCCCCCCCCCCCC | 29.36 | - | |
107 | Phosphorylation | SKMSFSKTHSTATMP CCCCCCCCCCCCCCC | 21.62 | 28348404 | |
109 | Phosphorylation | MSFSKTHSTATMPPP CCCCCCCCCCCCCCC | 25.60 | 21712546 | |
110 | Phosphorylation | SFSKTHSTATMPPPI CCCCCCCCCCCCCCC | 20.67 | 28348404 | |
112 | Phosphorylation | SKTHSTATMPPPINP CCCCCCCCCCCCCCH | 30.24 | 27251275 | |
128 | Phosphorylation | LASLQHNSILTPTRV HHHHHCCCCCCCCCC | 19.49 | 25627689 | |
131 | Phosphorylation | LQHNSILTPTRVSSS HHCCCCCCCCCCCCC | 22.42 | 25159151 | |
146 | Phosphorylation | ATKQKVLSPPHIKAD CCCCCCCCCCCEECC | 39.10 | 30266825 | |
151 | Ubiquitination | VLSPPHIKADFNLAD CCCCCCEECCCCCCC | 38.58 | - | |
153 (in isoform 1) | Ubiquitination | - | 28.15 | 21890473 | |
157 (in isoform 1) | Ubiquitination | - | 22.13 | 21890473 | |
173 (in isoform 4) | Phosphorylation | - | 46.41 | 27251275 | |
177 (in isoform 2) | Ubiquitination | - | 53.38 | 21890473 | |
177 | Ubiquitination | ELKTIDEKEELRNIL EEEECCCHHHHHHHH | 53.38 | 21906983 | |
205 | Phosphorylation | NNLPRGGSGSVLQDE CCCCCCCCCCCCCCH | 30.62 | 22617229 | |
207 | Phosphorylation | LPRGGSGSVLQDEEV CCCCCCCCCCCCHHH | 22.73 | 21712546 | |
210 (in isoform 4) | Phosphorylation | - | 54.64 | 24719451 | |
217 | Phosphorylation | QDEEVLASLERATLD CCHHHHHHHHHCCCC | 26.97 | 23403867 | |
226 | Ubiquitination | ERATLDFKPLHKPNG HHCCCCCCCCCCCCC | 46.46 | - | |
241 (in isoform 1) | Ubiquitination | - | 31.34 | 21890473 | |
247 | Phosphorylation | LGNCEKMSLSSKVSL CCCCEECCCCCCCCC | 35.85 | 28450419 | |
249 | Phosphorylation | NCEKMSLSSKVSLPP CCEECCCCCCCCCCC | 22.32 | 27251275 | |
250 | Phosphorylation | CEKMSLSSKVSLPPI CEECCCCCCCCCCCC | 42.23 | 28450419 | |
251 | Ubiquitination | EKMSLSSKVSLPPIP EECCCCCCCCCCCCC | 32.25 | - | |
253 | Phosphorylation | MSLSSKVSLPPIPAV CCCCCCCCCCCCCCC | 38.61 | 25394399 | |
261 | O-linked_Glycosylation | LPPIPAVSNIKSLSF CCCCCCCCCCCCCCC | 34.64 | 23301498 | |
264 | Acetylation | IPAVSNIKSLSFPKL CCCCCCCCCCCCCCC | 49.98 | 25953088 | |
264 (in isoform 2) | Ubiquitination | - | 49.98 | 21890473 | |
264 | Ubiquitination | IPAVSNIKSLSFPKL CCCCCCCCCCCCCCC | 49.98 | 21890473 | |
265 | Phosphorylation | PAVSNIKSLSFPKLD CCCCCCCCCCCCCCC | 26.00 | 28857561 | |
267 | Phosphorylation | VSNIKSLSFPKLDSD CCCCCCCCCCCCCCC | 46.74 | 23911959 | |
269 (in isoform 4) | Phosphorylation | - | 32.68 | 27251275 | |
270 | Ubiquitination | IKSLSFPKLDSDDSN CCCCCCCCCCCCCCC | 64.02 | - | |
271 (in isoform 4) | Phosphorylation | - | 8.52 | 24719451 | |
273 | Phosphorylation | LSFPKLDSDDSNQKT CCCCCCCCCCCCHHH | 54.47 | 26074081 | |
276 | Phosphorylation | PKLDSDDSNQKTAKL CCCCCCCCCHHHHHH | 46.26 | 26074081 | |
280 | Phosphorylation | SDDSNQKTAKLASTF CCCCCHHHHHHHHHH | 21.18 | 26074081 | |
281 (in isoform 4) | Phosphorylation | - | 16.35 | 27251275 | |
282 | Acetylation | DSNQKTAKLASTFHS CCCHHHHHHHHHHHH | 50.22 | 25953088 | |
285 | Phosphorylation | QKTAKLASTFHSTSC HHHHHHHHHHHHHHH | 41.88 | 23312004 | |
286 | Phosphorylation | KTAKLASTFHSTSCL HHHHHHHHHHHHHHH | 21.54 | 23312004 | |
289 | Phosphorylation | KLASTFHSTSCLRNG HHHHHHHHHHHHHCC | 20.16 | 21757351 | |
290 | Phosphorylation | LASTFHSTSCLRNGT HHHHHHHHHHHHCCC | 18.19 | 28857561 | |
291 | Phosphorylation | ASTFHSTSCLRNGTF HHHHHHHHHHHCCCC | 17.73 | 28555341 | |
297 | Phosphorylation | TSCLRNGTFQNSLKP HHHHHCCCCCCCCCC | 26.12 | 26270265 | |
301 | Phosphorylation | RNGTFQNSLKPSTQS HCCCCCCCCCCCCCC | 27.30 | 26270265 | |
317 (in isoform 4) | Phosphorylation | - | 24.96 | 24719451 | |
328 | Ubiquitination | LSALNLDSGTEMPAL CEEEECCCCCCCCCC | 51.27 | 21890473 | |
328 (in isoform 1) | Ubiquitination | - | 51.27 | 21890473 | |
328 | Ubiquitination | LSALNLDSGTEMPAL CEEEECCCCCCCCCC | 51.27 | 21890473 | |
331 (in isoform 4) | Phosphorylation | - | 46.85 | 24719451 | |
350 (in isoform 4) | Phosphorylation | - | 40.40 | 27251275 | |
353 (in isoform 4) | Phosphorylation | - | 41.74 | 24719451 | |
475 | Ubiquitination | KEMGFELKDIKEVLL HHCCCCHHCHHHHEE | 50.65 | - | |
478 | Ubiquitination | GFELKDIKEVLLLHN CCCHHCHHHHEECCC | 52.48 | - | |
502 | Phosphorylation | LMARAGAS------- HHHHHCCC------- | 39.58 | 18452278 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of UBAP1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UBAP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UBAP1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
VP37A_HUMAN | VPS37A | physical | 21757351 | |
TS101_HUMAN | TSG101 | physical | 21757351 | |
UBAP1_HUMAN | UBAP1 | physical | 22405001 | |
TS101_HUMAN | TSG101 | physical | 22405001 | |
VPS28_HUMAN | VPS28 | physical | 22405001 | |
VP37A_HUMAN | VPS37A | physical | 22405001 | |
K1468_HUMAN | KIAA1468 | physical | 22863883 | |
TS101_HUMAN | TSG101 | physical | 24284069 | |
VP37A_HUMAN | VPS37A | physical | 24284069 | |
TS101_HUMAN | TSG101 | physical | 26456826 | |
UBC_HUMAN | UBC | physical | 26456826 | |
ITA5_HUMAN | ITGA5 | physical | 26456826 | |
VP37A_HUMAN | VPS37A | physical | 28514442 | |
VP37B_HUMAN | VPS37B | physical | 28514442 | |
TS101_HUMAN | TSG101 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-205, AND MASSSPECTROMETRY. |